loadpatents
name:-0.0080299377441406
name:-0.23400688171387
name:-0.0060980319976807
Lohmann; Matthias Patent Filings

Lohmann; Matthias

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lohmann; Matthias.The latest application filed is for "azetidine compounds as grp119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders".

Company Profile
0.5.6
  • Lohmann; Matthias - Frankfurt am Main DE
  • LOHMANN; Matthias - Frankfurt DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Grant 10,392,366 - Schwink , et al. A
2019-08-27
Azetidine Compounds As Grp119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders
App 20180237419 - Schwink; Lothar ;   et al.
2018-08-23
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Grant 9,908,868 - Schwink , et al. March 6, 2
2018-03-06
Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Grant 9,896,434 - Schwink , et al. February 20, 2
2018-02-20
Serpins: methods of therapeutic .beta.-cell regeneration and function
Grant 9,763,998 - Kulkarni , et al. September 19, 2
2017-09-19
Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Grant 9,758,520 - Schwink , et al. September 12, 2
2017-09-12
Substituted Indanone Compounds As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders
App 20170029405 - SCHWINK; Lothar ;   et al.
2017-02-02
Isoindolinone Compounds As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders
App 20170022182 - SCHWINK; Lothar ;   et al.
2017-01-26
Substituted Fused Heterocycles As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders
App 20170022198 - SCHWINK; Lothar ;   et al.
2017-01-26
Serpins: Methods Of Therapeutic Beta-cell Regeneration And Function
App 20160002316 - MARGERIE; Daniel ;   et al.
2016-01-07
Serpins: Methods Of Therapeutic B-cell Regeneration And Function
App 20150366940 - Kulkarni; Rohit N. ;   et al.
2015-12-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed